From: The burden of metastatic disease of the femur on the Medicare system
Year | Men <65 | Women <65 | <65 group | Men 65+ | Women 65+ | 65+ group | Total |
---|---|---|---|---|---|---|---|
2005 | 47 | 80 | 127 | 507 | 619 | 1126 | 1253 |
2006 | 59 | 89 | 148 | 515 | 687 | 1202 | 1350 |
2007 | 57 | 91 | 148 | 538 | 689 | 1227 | 1375 |
2008 | 61 | 106 | 167 | 490 | 585 | 1075 | 1242 |
2009 | 57 | 97 | 154 | 474 | 651 | 1125 | 1279 |
2010 | 48 | 115 | 163 | 467 | 548 | 1015 | 1178 |
2011 | 60 | 106 | 166 | 478 | 578 | 1056 | 1222 |
2012 | 64 | 121 | 185 | 491 | 613 | 1104 | 1289 |
2013a | – | – | – | – | – | – | 1372 |
2014a | – | – | – | – | – | – | 1364 |
r2 | 0.20 | 0.84 | 0.80 | 0.42 | 0.29 | 0.36 | 0.02 |
p value | 0.27 | 0.001 | 0.003 | 0.08 | 0.17 | 0.11 | 0.68 |
Co (LCL; UCL) | 1.11 (−1.11; 3.32) | 5.18 (2.89; 7.46) | 6.29 (3.16; 9.41) | −6.26 (−13.66; 1.13) | −11.24 (−28.89; 6.42) | −17.50 (−40.70; 5.70) | 3.41 (−15.20; 22.01) |